STOCK WARRANTS AND STOCK OPTION (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 05, 2020 |
Jun. 05, 2020 |
May 04, 2020 |
Aug. 08, 2019 |
Sep. 28, 2021 |
Oct. 25, 2019 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2012 |
Apr. 07, 2020 |
Oct. 24, 2019 |
|
Number of warrants outstanding | 120,000 | 1,002,500 | 1,002,500 | ||||||||||||
Exercise price of warrants | $ 2.00 | $ 3 | $ 3 | ||||||||||||
Fair value of warrants issued | $ 220,000 | ||||||||||||||
Unrecognized compensation expense | $ 813,000 | $ 656,000 | |||||||||||||
Share-based compensation expense | $ 147,163 | $ 0 | $ 334,228 | $ 41,302 | $ 273,443 | $ 44,082 | |||||||||
Exercise price per share | $ 0.50 | $ 0.50 | |||||||||||||
Options vested | 320,000 | 320,000 | |||||||||||||
Exercise price | $ 2.00 | ||||||||||||||
Warrants issued to purchase common shares | 1,219,512 | ||||||||||||||
Non Employee Stock Warrants [Member] | |||||||||||||||
Number of warrants outstanding | 2,629,391 | 2,629,391 | 584,317 | 598,414 | |||||||||||
Stock option granted | 2,222,012 | 440,000 | 916,579 | ||||||||||||
Exercise price | $ 2 | ||||||||||||||
Warrants issued to purchase common shares | 1,219,512 | ||||||||||||||
Fair value of detached free-standing stock warrants granted | $ 1,939,756 | 695,454 | $ 915,124 | $ 160,544 | |||||||||||
Michael A. Lanphere [Member] | |||||||||||||||
Number of warrants outstanding | 454,097 | 454,097 | |||||||||||||
Reduction in related party debt | $ 65,875 | ||||||||||||||
Common stock shares issued to option exercised | 454,097 | ||||||||||||||
Michael A. Lanphere [Member] | Non employee stock options [Member] | |||||||||||||||
Expected lives | 5 years | ||||||||||||||
Loan agreement description | Mr. Lanphere as a Stock Fee under each Agreement was an estimate and varied based on the loan amount and the price of our common stock on the day of the loan and was calculated by this formula: 60% or 80% of the loan amount divided by the Company’s stock price on the day of the loan, but at a price per share no higher than ($0.025) | ||||||||||||||
2019 Equity Incentive Plans [Member] | |||||||||||||||
Stock option granted | 1,894 | 2,521,922 | 2,285,028 | ||||||||||||
Common stock acquire | $ 236,000 | ||||||||||||||
Common stock authorized shares | 2,921,861 | 2,921,861 | 2,521,921 | 3,848,467 | |||||||||||
Stock option descriptions | its common stock at exercise prices ranging from $1.645 to $3.30 to certain employees and key consultants. The fair value of the options granted was approximately $515,000. The stock options vest monthly and quarterly over 1 to 3-year terms. | ||||||||||||||
Total stock option vested shares | 15,000 | ||||||||||||||
Stock option vested shares | 1,893,347 | 1,893,347 | 1,202,168 | 539,847 | |||||||||||
Stock option issued | $ 926,606 | $ 926,606 | $ 1,326,545 | $ 1,563,439 | |||||||||||
Stock option non-vested shares | 1,028,514 | 1,028,514 | 1,319,753 | 1,745,181 | |||||||||||
Asset Purchase Agreement [Member] | IDTEC [Member] | |||||||||||||||
Number of warrants outstanding | 320,000 | 320,000 | |||||||||||||
Exercise price of warrants | $ 0.50 | ||||||||||||||
Expected lives | 5 years | ||||||||||||||
8% Series A-1 Convertible Preferred Stock Investment agreement [Member] | First Capital Ventures "FCV" [Member] | |||||||||||||||
Number of warrants outstanding | 144,317 | 144,317 | |||||||||||||
Exercise price of warrants | $ 1.039375 | ||||||||||||||
Convertible preferred stock shares sold | 1,000,000 | ||||||||||||||
Sale of stock price per share | $ 1.00 | ||||||||||||||
Common stock shares issuable upon exercise of warrants to SPV | 144,317 | ||||||||||||||
Consultant [Member] | 2019 Equity Incentive Plans [Member] | |||||||||||||||
Options exercisable per share | $ 0.2635 | ||||||||||||||
Stock option granted | 48,106 | ||||||||||||||
Common stock acquire | $ 50,000 | ||||||||||||||
Stock options vested | 50,000 | 0 | |||||||||||||
David Gandini [Member] | |||||||||||||||
Common stock acquire | $ 721,588 | ||||||||||||||
Stock options vested | 521,146 | 240,521 | |||||||||||||
Option vesting terms | (i) 200,439 Pre-Vesting Option Shares representing the monthly vesting option shares for the ten months ended October 31, 2019 to vest on November 1, 2019; and (ii) the remaining 40,090 Pre-Vesting Option Shares representing the monthly vesting option shares for the two months ended December 31, 2019 shall vest on January 1, 2020. | ||||||||||||||
Installments period description | The stock options vest in 36 equal monthly installments of 20,044 shares during the three-year term of his Employment Agreement. | ||||||||||||||
Exercise price per share | $ 0.2634 | ||||||||||||||
Expected lives | 10 years | ||||||||||||||
Kevin Moore [Member] | |||||||||||||||
Common stock acquire | $ 1,058,329 | ||||||||||||||
Exercise price per share | $ 0.2635 | ||||||||||||||
Expected lives | 5 years | ||||||||||||||
Stock option descriptions | stock options to vest in 36 equal monthly installments of 29,398 shares during the three-year term of the Moore Agreement | ||||||||||||||
Options vested | 352,776 | 58,796 | |||||||||||||
Kevin Moore [Member] | Employment Agreement [Member] | |||||||||||||||
Common stock acquire | $ 1,058,328 | ||||||||||||||
Stock options vested | 411,572 | 58,796 | |||||||||||||
Installments period description | The stock options vest in 36 equal monthly installments of 29,398 shares during the three-year term of his Employment Agreement | ||||||||||||||
Exercise price per share | $ 0.2635 | ||||||||||||||
Expected lives | 3 years | ||||||||||||||
Nick Noceti [Member] | |||||||||||||||
Common stock acquire | $ 24,053 | ||||||||||||||
Exercise price per share | $ 0.2635 | ||||||||||||||
Expected lives | 5 years | ||||||||||||||
Reduction in related party debt | $ 127,480 | ||||||||||||||
Options vested | 12,026 | 0 | |||||||||||||
Charles Bennington [Member] | |||||||||||||||
Common stock acquire | $ 24,053 | ||||||||||||||
Exercise price per share | $ 0.2635 | ||||||||||||||
Expected lives | 5 years | ||||||||||||||
Reduction in related party debt | $ 9,656 | ||||||||||||||
Options vested | 24,053 | 0 | |||||||||||||
Executive Stock Options [Member] | |||||||||||||||
Number of warrants outstanding | 1,553,152 | 1,553,152 | 981,771 | 2,285,028 | |||||||||||
Share-based compensation expense | $ 630,027 | $ 343,549 | $ 239,478 | $ 95,566 | |||||||||||
Options exercisable per share | $ 0.2634 | $ 0.2634 | $ 0.2641 | $ 0.26341 | |||||||||||
Executive Stock Options [Member] | Maximum [Member] | |||||||||||||||
Options exercisable per share | $ 3.38 | $ 3.38 |